SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-21-000487
Filing Date
2021-11-05
Accepted
2021-11-05 10:01:22
Documents
12
Period of Report
2021-10-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rgbp110521form8k.htm   iXBRL 8-K 20212
  Complete submission text file 0001607062-21-000487.txt   186230

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20211012.xsd EX-101.SCH 3052
3 XBRL LABEL FILE rgbp-20211012_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE rgbp-20211012_pre.xml EX-101.PRE 22377
5 EXTRACTED XBRL INSTANCE DOCUMENT rgbp110521form8k_htm.xml XML 3276
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 211382884
SIC: 2834 Pharmaceutical Preparations